Vue transversale globale

Toutes les maladies

Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.

Périmètre

Filtrer toute la vue

Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.

Tout réinitialiser Actualisation…
Essais et traitements6003Données cliniques et programmes
Recherches et trouvailles21Pipeline scientifique
Publications4910Références reliées aux maladies
Pistes exploratoires0Hypothèses non validées
10934 résultats correspondants · 41 visibles sur cette page dans le périmètre Toutes les maladies
Niveau clinique

Études et traitements 6003

Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
LBL-047 for Injection NCT07323173 · A Study to Assess the Safety and PK/PD of LBL-047 in Healthy Adults and Patients… Lupus À vérifier Phase 1 RECRUITING A Double-blind, Randomized, Placebo-controlled, Dose-escalation Phase I St… À vérifier ClinicalTrials.gov 2026-09-01 09:22:26 Détail
Low Dose Mesenchymal Stem Cells (MSCs) NCT02633163 · Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE) Lupus Thérapie cellulaire Phase 2 COMPLETED The purpose of this study is to evaluate the safety of mesenchymal stromal… À vérifier ClinicalTrials.gov 2026-09-01 09:22:26 Détail
Obecabtagene autoleucel NCT07053800 · LUMINA — Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With A… Lupus À vérifier Phase 2 RECRUITING The purpose of this trial is to evaluate the efficacy and safety of obecab… À vérifier ClinicalTrials.gov 2026-09-01 09:22:26 Détail
obinutuzumab (RO5072759) NCT07767188 · A Trial to Explore the Efficacy and Safety of O-triple as Initial Therapy in the… Lupus À vérifier Phase 3 NOT_YET_RECRUITING This is a prospective single-arm multi-center trial to evaluate the effica… À vérifier ClinicalTrials.gov 2026-09-01 09:22:26 Détail
Predictors of ICU Admission and In-Hospital Mortality in Hospitalized… NCT07783711 · Predictors of ICU Admission and In-Hospital Mortality in Hospitalized Patients W… Lupus À vérifier À vérifier NOT_YET_RECRUITING To identify clinical and laboratory predictors of ICU admission and in-hos… À vérifier ClinicalTrials.gov 2026-09-01 09:22:26 Détail
IM19 CAR-T cells NCT06513429 · IM19 CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus (SLE) Lupus Thérapie cellulaire Non applicable RECRUITING The study is a single-arm, open-label clinical trial intended to recruit 6… À vérifier ClinicalTrials.gov 2026-09-01 09:22:25 Détail
IMVT-1402 NCT06980805 · A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Partici… Lupus À vérifier Phase 2 ACTIVE_NOT_RECRUITING The purpose of the study is to assess the efficacy, safety and tolerabilit… À vérifier ClinicalTrials.gov 2026-09-01 09:22:25 Détail
KYV-101 anti-CD19 CAR-T cell therapy NCT05938725 · KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Thera… Lupus Thérapie cellulaire Phase 1/2 TERMINATED A Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy for Subjects… À vérifier ClinicalTrials.gov 2026-09-01 09:22:25 Détail
KYV-101 anti-CD19 CAR-T cell therapy NCT06342960 · KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Thera… Lupus Thérapie cellulaire Phase 1/2 TERMINATED A Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy for Subjects… À vérifier ClinicalTrials.gov 2026-09-01 09:22:25 Détail
VIOLET — NIS to Examine Disease Activity in SLE Patients Treated With… NCT07424261 · NCT07424261 Lupus À vérifier À vérifier RECRUITING VIOLET is a prospective, single-arm, multi-centre, non-interventional stud… À vérifier ClinicalTrials.gov 2026-09-01 09:22:25 Détail
Echopulse NCT04009863 · HIFU Ablation vs Fixed-dose RAI-131 Therapy in Moderate-sized Non-toxic MNG Cancer Immunomodulation · Traitement symptomatique Non applicable COMPLETED After obtaining informed consent, eligible subjects will be assigned rando… À vérifier ClinicalTrials.gov 2026-09-01 09:22:24 Détail
Magnetic Resonance-Guided High Intensity Focused Ultrasound NCT04791228 · A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors Cancer À vérifier Phase 2 WITHDRAWN This is a pilot study of LTLD with MR-HIFU hyperthermia followed by ablati… À vérifier ClinicalTrials.gov 2026-09-01 09:22:24 Détail
Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation o… NCT03996005 · MRI-TULSAP — MRI- Guided Transurethral Ultrasound Ablation of Localized Prostate… Cancer Thérapie génique Non applicable COMPLETED Primary purpose : Evaluation of the efficiency and safety of an alternativ… À vérifier ClinicalTrials.gov 2026-09-01 09:22:24 Détail
Assessment of Endoscopic Tip Control Using a Novel Score Based on the… NCT05660317 · NCT05660317 Cancer À vérifier À vérifier UNKNOWN Colorectal cancer is the third most common malignancy worldwide and the se… À vérifier ClinicalTrials.gov 2026-09-01 09:22:23 Détail
High intensity focused ultrasound, HIFU NCT00637364 · HIFU Pancreas — High Intensity Focused Ultrasound Tumor Treatment for Pancreatic… Cancer Traitement symptomatique Phase 1/2 SUSPENDED This is an open-label, non-randomized, single-center, therapeutic trial in… À vérifier ClinicalTrials.gov 2026-09-01 09:22:23 Détail
IRE + intratumoral mitazalimab (CD40 antibody) injection NCT06205849 · Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE… Cancer À vérifier Phase 1 RECRUITING This is a phase I study of an agonistic CD40 antibody (mitazalimab) inject… À vérifier ClinicalTrials.gov 2026-09-01 09:22:23 Détail
IRIS™ Thermal Ablation Device NCT07461818 · POC — Point of Care - Triage and Treatment for Cervical Pre-cancer Cancer À vérifier Non applicable RECRUITING This study evaluates a modified two-probe thermal ablation protocol using… À vérifier ClinicalTrials.gov 2026-09-01 09:22:23 Détail
Irreversible Electroporation (IRE) NCT02791503 · CROSSFIRE Trial: Comparing the Efficacy of Irreversible Electroporation With Rad… Cancer À vérifier Non applicable COMPLETED Most prostate cancer treatment research in the last decade has been focuse… À vérifier ClinicalTrials.gov 2026-09-01 09:22:23 Détail
LITT NCT04699773 · LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138) Cancer À vérifier Non applicable RECRUITING The purpose of this study is to evaluate the treatment regimen of using La… À vérifier ClinicalTrials.gov 2026-09-01 09:22:23 Détail
Medical device containing Y-90 microspheres delivered intratumorally… NCT07155850 · Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant T… Cancer Traitement symptomatique · Thérapie génique Non applicable RECRUITING The goal of this clinical investigation is to learn if a new type of radio… À vérifier ClinicalTrials.gov 2026-09-01 09:22:23 Détail
Découverte scientifique

Recherches et trouvailles 21

Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation Sclérose latérale amyotrophique Neuroprotection · Immunomodulation Découverte fondamentale Exploratoire Modulation immunométabolique de la microglie · NRF2 / inflammation microgl… Piste mécanistique visant à reprogrammer la réponse inflammatoire de la microglie. Le lien avec la SLA reste exploratoi… Revue scientifique 2024-07-01 Détail
Bibliographie

Publications 4910

Références bibliographiques de la base locale et accès à leur source originale.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
A comparative study of the role of crocin and sitagliptin in attenuat… Standard Oral Hypoglycemic Agent · PMID 31394428 Maladie rénale chronique Ralentissement de la progression · Immunomodulation Publication PubMed Voir la publication source Type 1 diabetes mellitus (T1DM) describes a complex group of metabolic disorders associated with elevated blood glucose… Environmental toxicology and pharmacology 2026-11-15 04:38:02 Source
Anti diabetic effect of Achyranthes rubrofusca leaf extracts on allox… Standard Oral Hypoglycemic Agent · PMID 21454169 Maladie rénale chronique À vérifier Publication PubMed Voir la publication source The aqueous and ethanolic extracts of Achyranthes rubrofuca leaves (AR) were studied for their hypoglycemic activity. T… Pakistan journal of pharmaceutical sciences 2026-11-15 04:38:02 Source
Antihyperglycemic and hypolipidemic activities of Setaria italica see… Standard Oral Hypoglycemic Agent · PMID 20869855 Maladie rénale chronique À vérifier Publication PubMed Voir la publication source Setaria italica is commonly known as Foxtail millet. In India it is chiefly cultivated in Andhra Pradesh and Tamilnadu.… Pathophysiology : the official journal of the Internat… 2026-11-15 04:38:02 Source
Enhancing neoadjuvant immunotherapy for locally advanced rectal cance… HJB647 high dose · PMID 42860120 Cancer Immunomodulation Publication PubMed Voir la publication source Conventional surgery for locally advanced rectal cancer (LARC) faces challenges including difficult sphincter preservat… Biomaterials 2026-11-15 04:37:50 Source
Oxygen-vacancy-rich LDH sonosensitizers potentiate narrow-spectrum an… HJB647 high dose · PMID 42910182 Insuffisance cardiaque Neuroprotection · Immunomodulation · Thérapie génique Publication PubMed Voir la publication source Mixed bacterial infections, including Gram-positive and Gram-negative pathogens, remain a major global health concern.… Bioactive materials 2026-11-15 04:37:50 Source
Respiratory Support With Nasal High Flow Reduces Opioid Requirements… HJB647 high dose · PMID 42699223 Insuffisance cardiaque À vérifier Publication PubMed Voir la publication source Nasal high flow (NHF) improves oxygenation, reduces the work of breathing, and stabilizes ventilation. In endoscopic re… DEN open 2026-11-15 04:37:50 Source
Feasibility of a Deep-Learning Model for Objective Visualization-Qual… Lithotripsy · PMID 42898633 Maladie coronarienne À vérifier Publication PubMed Voir la publication source During peroral cholangioscopy-guided electrohydraulic lithotripsy (EHL), stone fragmentation obscures the visual field… DEN open 2026-11-15 04:37:45 Source
Impact of calcium burden, lesion preparation, and lithotripsy on sten… Lithotripsy · PMID 42777787 Maladie coronarienne À vérifier Publication PubMed Voir la publication source Stent underexpansion in severely calcified coronary lesions increases the risk of target vessel failure. Intravascular… International journal of cardiology 2026-11-15 04:37:45 Source
Intravascular lithotripsy for calcific stenosis of the abdominal aort… Lithotripsy · PMID 43001236 Maladie coronarienne À vérifier Publication PubMed Voir la publication source Takayasu arteritis is a rare large-vessel vasculitis that predominantly affects the aorta and its major branches. Altho… Journal of vascular surgery cases and innovative techn… 2026-11-15 04:37:45 Source
Placenta-derived mesenchymal stem cells for prenatal myelomeningocele… cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells · PMID 42… Sclérose en plaques · Sclérose latérale amyotrophique · Sclérose laté… Thérapie cellulaire Publication PubMed Voir la publication source Résumé non disponible dans la base locale. Annals of translational medicine 2026-11-15 04:37:41 Source
Synovial Biomarker Modulation and Clinical Response to Umbilical Cord… cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells · PMID 42… Sclérose en plaques · Sclérose latérale amyotrophique · Sclérose laté… Immunomodulation · Thérapie cellulaire Publication PubMed Voir la publication source ObjectiveUmbilical cord-derived mesenchymal stromal cells (UC-MSCs) are a promising treatment for knee osteoarthritis (… Cartilage 2026-11-15 04:37:41 Source
Design, synthesis, and biological evaluation of 1H-1,2,4-triazole-3-c… B007 · PMID 42142713 Insuffisance cardiaque À vérifier Publication PubMed Voir la publication source The apelin receptor (AplnR) is a prominent peptide-binding Class A G protein-coupled receptor (GPCR) involved in the re… Bioorganic & medicinal chemistry letters 2026-11-15 04:37:34 Source
Programmable Nanobody-Targeting Chimeras Enable Intracellular Viral P… B007 · PMID 42467897 Myasthénie À vérifier Publication PubMed Voir la publication source Chronic hepatitis B virus (HBV) infection remains a major global health challenge, largely because current antiviral th… Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026-11-15 04:37:34 Source
Understanding the Selectivity of Selective Oxidation of Propane to Ac… B007 · PMID 41768713 Myasthénie À vérifier Publication PubMed Voir la publication source In this work, we have performed a quantum chemical investigation for the selective oxidation of propane toward acrylic… ACS omega 2026-11-15 04:37:34 Source
Comparative efficacy and acceptability of antidepressants in the long… Milnacipran · PMID 43008763 Myopathies À vérifier Publication PubMed Voir la publication source Major depressive disorder carries high risks of relapse and chronicity, necessitating treatments that achieve and maint… The lancet. Psychiatry 2026-11-15 04:37:30 Source
Polysubstance-Induced Vasoplegia Managed with Venoarterial Extracorpo… Milnacipran · PMID 43014364 Myopathies À vérifier Publication PubMed Voir la publication source While the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) becomes increasingly commonplace in overdos… Clinical practice and cases in emergency medicine 2026-11-15 04:37:30 Source
Early Outcome of a Single Peri-Tendinous Hyaluronic Acid Injection fo… Sodium hyaluronate with mannitol (Ostenil Tendon) · PMID 33132010 Myopathies Traitement symptomatique Publication PubMed Voir la publication source The aim of this study was to evaluate the efficacy and safety of a single, peri-tendinous injection of hyaluronic acid… Foot (Edinburgh, Scotland) 2026-11-15 04:37:29 Source
Engineered stem cell-derived CD16-enhanced universal NKT cells improv… Tafasitamab and NK cells · PMID 43008138 Cancer Immunomodulation · Thérapie cellulaire Publication PubMed Voir la publication source Monoclonal antibody (mAb)-based therapies have revolutionized cancer treatment; however, their clinical efficacy is oft… Cancer immunology research 2026-11-15 04:37:24 Source
Precision Fc remodeling via glycosylation-competent CHO display enabl… Tafasitamab and NK cells · PMID 41923108 Cancer Immunomodulation Publication PubMed Voir la publication source BACKGROUND: Improving tumor cell clearance by therapeutic antibodies remains a translational bottleneck because wild-ty… Journal of biological engineering 2026-11-15 04:37:24 Source
The Fc-engineered CD19 antibody MOR208 (XmAb5574) induces natural kil… Tafasitamab and NK cells · PMID 23277329 Lupus À vérifier Publication PubMed Voir la publication source Résumé non disponible dans la base locale. Leukemia 2026-11-15 04:37:24 Source
Exploration — prudence

Pistes exploratoires 0

Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.

Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Aucune piste exploratoire ne correspond aux filtres.